SELLAS Life Sciences (SLS) Debt to Equity (2013 - 2018)
SELLAS Life Sciences (SLS) reported Debt to Equity of $0.0 for Q3 2018, down 99.5% year-over-year from $0.83 in Q3 2017, and up 100.13% on a QoQ basis from -$3.13 in Q2 2018.
SELLAS Life Sciences (SLS) has 6 years of Debt to Equity data on file, last reported at $0.0 in Q3 2018.
- Quarterly Debt to Equity fell 99.5% year-over-year to $0.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $0.0 (down 99.5% YoY) and the FY2017 annual result came in at $5.31, up 1652.09% from the prior year.
- Debt to Equity grew to $0.0 in Q3 2018 per SLS's latest filing, from -$3.13 in the prior quarter.
- Across five years, Debt to Equity topped out at $5.31 in Q4 2017 and bottomed at -$7.34 in Q1 2018.
- The 5-year median for Debt to Equity is $0.23 (2014), against an average of $0.0.
- The widest annual swing landed in 2017, when Debt to Equity jumped 1652.09%; it then tumbled 1684.84% in 2018.
- Tracing SLS's Debt to Equity over 5 years: stood at $0.23 in 2014, then slumped by 270.47% to -$0.39 in 2015, then increased by 11.51% to -$0.34 in 2016, then jumped by 1652.09% to $5.31 in 2017, then slumped by 99.92% to $0.0 in 2018.
- Per Business Quant, the three latest SLS Debt to Equity figures stand at $0.0 (Q3 2018), -$3.13 (Q2 2018), and -$7.34 (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | -3.13 |
| Mar 31, 2018 | -7.34 |
| Dec 31, 2017 | 5.31 |
| Sep 30, 2017 | 0.83 |
| Jun 30, 2017 | 0.68 |
| Mar 31, 2017 | 0.46 |
| Dec 31, 2016 | -0.34 |
| Sep 30, 2016 | 0.99 |
| Jun 30, 2016 | 1.14 |
| Mar 31, 2016 | 0.30 |
| Dec 31, 2015 | -0.39 |
| Sep 30, 2015 | 0.18 |
| Jun 30, 2015 | 0.13 |
| Mar 31, 2015 | 0.13 |
| Dec 31, 2014 | 0.23 |
| Sep 30, 2014 | 0.30 |
| Jun 30, 2014 | 0.36 |
| Mar 31, 2014 | 0.21 |
| Dec 31, 2013 | 1.68 |
| Sep 30, 2013 | 0.28 |
| Jun 30, 2013 | 0.64 |